2015
A functional polymorphism in the interleukin-1beta and severity of nicotine dependence in male schizophrenia: A case-control study
Zhang XY, Chen DC, Tan YL, Tan SP, Luo X, Zuo L, Rao W, Yu Q, Kou C, Allen M, Correll CU, Wu J, Soares JC. A functional polymorphism in the interleukin-1beta and severity of nicotine dependence in male schizophrenia: A case-control study. Journal Of Psychiatric Research 2015, 64: 51-58. PMID: 25858413, DOI: 10.1016/j.jpsychires.2015.03.015.Peer-Reviewed Original ResearchConceptsT polymorphismNicotine dependenceCase-control studyIL-1 participatesNegative Syndrome ScaleSignificant differencesMale smokersMale patientsSmoking statusLung diseaseMale schizophreniaSmoking indexIL-1betaChronic schizophreniaFagerstrom TestHealthy controlsInterleukin-1betaC genotypeSmokersT genotypePatientsSmoking behaviorControl groupMale controlsSyndrome Scale
2003
Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the μ‐opioid receptor locus (OPRM1)
Hernandez‐Avila C, Wand G, Luo X, Gelernter J, Kranzler HR. Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the μ‐opioid receptor locus (OPRM1). American Journal Of Medical Genetics Part B Neuropsychiatric Genetics 2003, 118B: 60-65. PMID: 12627468, DOI: 10.1002/ajmg.b.10054.Peer-Reviewed Original ResearchConceptsCortisol responseAsn40 alleleAsn40Asp polymorphismAsp40 alleleCortisol concentrationsCortisol time curveMu-opioid receptor proteinOpioid antagonist naloxoneMin post infusionPeak cortisol responsePlasma ACTH concentrationsEnhanced cortisol responseHigher cortisol concentrationsWarrants further investigationAsp40 variantIntravenous naloxoneOpioid blockadeNaloxone infusionAntagonist naloxonePlasma ACTHACTH concentrationsAgonist effectsPost infusionHealthy subjectsClinical relevance